Literature DB >> 29795201

Characterization and origin of heme precursors in amniotic fluid: lessons from normal and pathological pregnancies.

Hana Manceau1,2, Vincent Puy3, Hervé Puy2,4, Francoise Muller5, Katell Peoc'h6,7, Caroline M Schmitt2,4, Sophie Gil8, Thibaud Lefebvre2,4, Bichr Allaf5, Jonathan Rosenblatt9, Laurent Gouya2,4.   

Abstract

BACKGROUND: Heme is the prosthetic group of numerous proteins involved in vital processes such as oxygen transport, oxidative stress, and energetic mitochondrial metabolism. Free heme also plays a significant role at early stages of development and in cell differentiation processes. The metabolism of heme by the fetal placenta unit is not well-established in humans.
METHODS: In a retrospective study, we measured heme precursors in the amniotic fluid (AF) of 51 healthy women, and 10 AF samples from pregnancies with either upper or lower intestinal atresia or ileus were also analyzed.
RESULTS: We showed that the porphyrin precursors aminolevulinic acid, porphobilinogen, and protoporphyrin IX are present at the limit of detection in the AF. Total porphyrin levels decreased progressively from week 13 to week 33 (p < 0.01). Interestingly, uroporphyrin, initially detected as traces, increased with maturation, in contrast to coproporphyrin. Uro- and coproporphyrins were type I immature isomers (>90%), suggesting a lack of maturity in the fetal compartment of the heme pathway. Finally, the differential analysis of AF from normal and pathological pregnancies demonstrated the predominant hepatic origin of fetal porphyrins excreted in the AF.
CONCLUSION: This study gives the first insight into heme metabolism in the AF during normal and pathological pregnancies.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29795201     DOI: 10.1038/s41390-018-0011-2

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  1 in total

1.  Rapid procedure for fecal porphyrin assay.

Authors:  W H Lockwood; V Poulos; E Rossi; D H Curnow
Journal:  Clin Chem       Date:  1985-07       Impact factor: 8.327

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.